Literature DB >> 25811966

Cytotoxic effect and mechanism inducing cell death of α-mangostin liposomes in various human carcinoma and normal cells.

Ruthairat Benjakul1, Lalana Kongkaneramit, Narong Sarisuta, Primchanien Moongkarndi, Christel C Müller-Goymann.   

Abstract

The aims of this study were to develop α-mangostin liposomes as well as to evaluate their physicochemical properties and cytotoxic activity. α-Mangostin liposomes were prepared using the reverse-phase evaporation method with lipid composition of phosphatidylcholine to cholesterol at 7 : 3 molar ratios; their physicochemical properties and antiproliferative activity were assessed using an MTT assay in four human carcinoma cells [that is, human lung epithelial carcinoma (Calu-3), human colon carcinoma (HT-29), human breast carcinoma (MCF-7), and human colon carcinoma (Caco-2) cells], and two human normal cells [that is, human dermal fibroblasts (HDF) and human adult low-calcium elevated temperature (HaCaT) keratinocytes]. Determinations of morphological changes and oligonucleosomal DNA fragments were also carried out. The liposomal dispersions obtained were unilamellar vesicles as confirmed by cryotransmission and freeze-fracture electron microscopy with a particle size of 114 nm and a ζ potential of -2.56 mV. The P-NMR spectra showed that α-mangostin molecules orientated in the phospholipid bilayer membrane. The α-mangostin could appreciably be entrapped with an efficiency and loading of 81 and 4%, respectively. The antiproliferative activity of α-mangostin liposomes in various cancer and normal cells showed a dose-dependent inhibition in all treated cell lines. The antiproliferative effect of α-mangostin liposomes was found to be associated with apoptosis, with differences in sensitivity among the cell lines treated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811966     DOI: 10.1097/CAD.0000000000000235

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  8 in total

1.  Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling.

Authors:  Sirinapha Klungsaeng; Veerapol Kukongviriyapan; Auemduan Prawan; Sarinya Kongpetch; Laddawan Senggunprai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-23       Impact factor: 3.000

2.  Inhibition of Cell Proliferation in an NRAS Mutant Melanoma Cell Line by Combining Sorafenib and α-Mangostin.

Authors:  Yun Xia; Ying Li; Kenneth D Westover; Jiaming Sun; Hongxiang Chen; Jianming Zhang; David E Fisher
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

Review 3.  Dental Application of Natural Products.

Authors:  Hiroshi Sakagami; Mineko Tomomura
Journal:  Medicines (Basel)       Date:  2018-02-14

4.  Design, synthesis and structure-activity relationships of mangostin analogs as cytotoxic agents.

Authors:  Xiao-Qian Chi; Cheng-Ting Zi; Hong-Mei Li; Liu Yang; Yong-Feng Lv; Jin-Yu Li; Bo Hou; Fu-Cai Ren; Jiang-Miao Hu; Jun Zhou
Journal:  RSC Adv       Date:  2018-12-12       Impact factor: 3.361

5.  Liposome-Encapsulated Bioactive Guttiferone E Exhibits Anti-Inflammatory Effect in Lipopolysaccharide-Stimulated MH-S Macrophages and Cytotoxicity against Human Cancer Cells.

Authors:  Jean Paul Dzoyem; Shashank Reddy Pinnapireddy; Hugues Fouotsa; Jana Brüßler; Frank Runkel; Udo Bakowsky
Journal:  Mediators Inflamm       Date:  2022-08-30       Impact factor: 4.529

6.  Effects of α-Mangostin on Viability, Growth and Cohesion of Multicellular Spheroids Derived from Human Breast Cancer Cell Lines.

Authors:  Giuseppe Scolamiero; Claudia Pazzini; Francesca Bonafè; Carlo Guarnieri; Claudio Muscari
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

7.  α-Mangostin protects against high-glucose induced apoptosis of human umbilical vein endothelial cells.

Authors:  Yanli Luo; Minxiang Lei
Journal:  Biosci Rep       Date:  2017-12-12       Impact factor: 3.840

Review 8.  Nanoformulations of α-Mangostin for Cancer Drug Delivery System.

Authors:  Lisna Meylina; Muchtaridi Muchtaridi; I Made Joni; Ahmed Fouad Abdelwahab Mohammed; Nasrul Wathoni
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.